<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-07-01" modified="2017-05-10" version="192">
<accession>Q02750</accession>
<name>MP2K1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Dual specificity mitogen-activated protein kinase kinase 1</fullName>
<shortName>MAP kinase kinase 1</shortName>
<shortName>MAPKK 1</shortName>
<shortName>MKK1</shortName>
<ecNumber>2.7.12.2</ecNumber>
</recommendedName>
<alternativeName>
<fullName>ERK activator kinase 1</fullName>
</alternativeName>
<alternativeName>
<fullName>MAPK/ERK kinase 1</fullName>
<shortName>MEK 1</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">MAP2K1</name>
<name type="synonym">MEK1</name>
<name type="synonym">PRKMK1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="25628" last="25631">
<title>Human T-cell mitogen-activated protein kinase kinases are related to yeast signal transduction kinases.</title>
<authorList>
<person name="Seger R."/>
<person name="Seger D."/>
<person name="Lozeman F.J."/>
<person name="Ahn N.G."/>
<person name="Graves L.M."/>
<person name="Campbell J.S."/>
<person name="Ericsson L."/>
<person name="Harrylock M."/>
<person name="Jensen A.M."/>
<person name="Krebs E.G."/>
</authorList>
<dbReference type="PubMed" id="1281467"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="11435" last="11439">
<title>Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2.</title>
<authorList>
<person name="Zheng C.-F."/>
<person name="Guan K.-L."/>
</authorList>
<dbReference type="PubMed" id="8388392"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="5523" last="5534">
<title>Kinase suppressor of Ras forms a multiprotein signaling complex and modulates MEK localization.</title>
<authorList>
<person name="Stewart S."/>
<person name="Sundaram M."/>
<person name="Zhang Y."/>
<person name="Lee J."/>
<person name="Han M."/>
<person name="Guan K.L."/>
</authorList>
<dbReference type="PubMed" id="10409742"/>
<dbReference type="DOI" id="10.1128/MCB.19.8.5523"/>
</citation>
<scope>PROTEIN SEQUENCE OF 35-45; 48-57; 175-183 AND 344-353</scope>
<scope>INTERACTION WITH KSR1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-218</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1994" name="EMBO J." volume="13" first="1123" last="1131">
<title>Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues.</title>
<authorList>
<person name="Zheng C.-F."/>
<person name="Guan K.-L."/>
</authorList>
<dbReference type="PubMed" id="8131746"/>
</citation>
<scope>PHOSPHORYLATION AT SER-218 AND SER-222</scope>
<scope>MUTAGENESIS OF LYS-97; SER-150; SER-212; SER-218 AND SER-222</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1998" name="Science" volume="280" first="734" last="737">
<title>Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.</title>
<authorList>
<person name="Duesbery N.S."/>
<person name="Webb C.P."/>
<person name="Leppla S.H."/>
<person name="Gordon V.M."/>
<person name="Klimpel K.R."/>
<person name="Copeland T.D."/>
<person name="Ahn N.G."/>
<person name="Oskarsson M.K."/>
<person name="Fukasawa K."/>
<person name="Paull K.D."/>
<person name="Vande Woude G.F."/>
</authorList>
<dbReference type="PubMed" id="9563949"/>
<dbReference type="DOI" id="10.1126/science.280.5364.734"/>
</citation>
<scope>CLEAVAGE BY ANTHRAX LETHAL FACTOR</scope>
<scope>PROTEIN SEQUENCE OF 9-17</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2000" name="Biochem. J." volume="352" first="739" last="745">
<title>Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.</title>
<authorList>
<person name="Vitale G."/>
<person name="Bernardi L."/>
<person name="Napolitani G."/>
<person name="Mock M."/>
<person name="Montecucco C."/>
</authorList>
<dbReference type="PubMed" id="11104681"/>
<dbReference type="DOI" id="10.1042/bj3520739"/>
</citation>
<scope>CLEAVAGE BY ANTHRAX LETHAL FACTOR</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Oncogene" volume="23" first="763" last="776">
<title>The MAP kinase pathway is required for entry into mitosis and cell survival.</title>
<authorList>
<person name="Liu X."/>
<person name="Yan S."/>
<person name="Zhou T."/>
<person name="Terada Y."/>
<person name="Erikson R.L."/>
</authorList>
<dbReference type="PubMed" id="14737111"/>
<dbReference type="DOI" id="10.1038/sj.onc.1207188"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="36609" last="36615">
<title>Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors.</title>
<authorList>
<person name="Beeser A."/>
<person name="Jaffer Z.M."/>
<person name="Hofmann C."/>
<person name="Chernoff J."/>
</authorList>
<dbReference type="PubMed" id="16129686"/>
<dbReference type="DOI" id="10.1074/jbc.M502306200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-298</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Science" volume="312" first="1211" last="1214">
<title>Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation.</title>
<authorList>
<person name="Mukherjee S."/>
<person name="Keitany G."/>
<person name="Li Y."/>
<person name="Wang Y."/>
<person name="Ball H.L."/>
<person name="Goldsmith E.J."/>
<person name="Orth K."/>
</authorList>
<dbReference type="PubMed" id="16728640"/>
<dbReference type="DOI" id="10.1126/science.1126867"/>
</citation>
<scope>INTERACTION WITH YOPJ</scope>
<scope>ACETYLATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="803" last="817">
<title>Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma.</title>
<authorList>
<person name="Burgermeister E."/>
<person name="Chuderland D."/>
<person name="Hanoch T."/>
<person name="Meyer M."/>
<person name="Liscovitch M."/>
<person name="Seger R."/>
</authorList>
<dbReference type="PubMed" id="17101779"/>
<dbReference type="DOI" id="10.1128/MCB.00601-06"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PPARG</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2008" name="Cell" volume="132" first="832" last="845">
<title>Final stages of cytokinesis and midbody ring formation are controlled by BRUCE.</title>
<authorList>
<person name="Pohl C."/>
<person name="Jentsch S."/>
</authorList>
<dbReference type="PubMed" id="18329369"/>
<dbReference type="DOI" id="10.1016/j.cell.2008.01.012"/>
</citation>
<scope>INTERACTION WITH BIRC6/BRUCE</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-286</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="J. Hepatol." volume="51" first="67" last="76">
<title>Protein kinase SGK1 enhances MEK/ERK complex formation through the phosphorylation of ERK2: implication for the positive regulatory role of SGK1 on the ERK function during liver regeneration.</title>
<authorList>
<person name="Won M."/>
<person name="Park K.A."/>
<person name="Byun H.S."/>
<person name="Kim Y.R."/>
<person name="Choi B.L."/>
<person name="Hong J.H."/>
<person name="Park J."/>
<person name="Seok J.H."/>
<person name="Lee Y.H."/>
<person name="Cho C.H."/>
<person name="Song I.S."/>
<person name="Kim Y.K."/>
<person name="Shen H.M."/>
<person name="Hur G.M."/>
</authorList>
<dbReference type="PubMed" id="19447520"/>
<dbReference type="DOI" id="10.1016/j.jhep.2009.02.027"/>
</citation>
<scope>INTERACTION WITH SGK1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2010" name="Mol. Cell. Biol." volume="30" first="4687" last="4697">
<title>VRK2 inhibits mitogen-activated protein kinase signaling and inversely correlates with ErbB2 in human breast cancer.</title>
<authorList>
<person name="Fernandez I.F."/>
<person name="Blanco S."/>
<person name="Lozano J."/>
<person name="Lazo P.A."/>
</authorList>
<dbReference type="PubMed" id="20679487"/>
<dbReference type="DOI" id="10.1128/MCB.01581-09"/>
</citation>
<scope>INTERACTION WITH VRK2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1998" name="Oncogene" volume="17" first="1447" last="1455">
<title>Signaling by dual specificity kinases.</title>
<authorList>
<person name="Dhanasekaran N."/>
<person name="Premkumar Reddy E."/>
</authorList>
<dbReference type="PubMed" id="9779990"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202251"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="Nat. Rev. Mol. Cell Biol." volume="5" first="875" last="885">
<title>The RAF proteins take centre stage.</title>
<authorList>
<person name="Wellbrock C."/>
<person name="Karasarides M."/>
<person name="Marais R."/>
</authorList>
<dbReference type="PubMed" id="15520807"/>
<dbReference type="DOI" id="10.1038/nrm1498"/>
</citation>
<scope>REVIEW ON ENZYME REGULATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="BioFactors" volume="35" first="407" last="416">
<title>The ERK signaling cascade--views from different subcellular compartments.</title>
<authorList>
<person name="Yao Z."/>
<person name="Seger R."/>
</authorList>
<dbReference type="PubMed" id="19565474"/>
<dbReference type="DOI" id="10.1002/biof.52"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="Genes Cancer" volume="2" first="195" last="209">
<title>The ERK cascade: distinct functions within various subcellular organelles.</title>
<authorList>
<person name="Wortzel I."/>
<person name="Seger R."/>
</authorList>
<dbReference type="PubMed" id="21779493"/>
<dbReference type="DOI" id="10.1177/1947601911407328"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2004" name="Nat. Struct. Mol. Biol." volume="11" first="1192" last="1197">
<title>Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.</title>
<authorList>
<person name="Ohren J.F."/>
<person name="Chen H."/>
<person name="Pavlovsky A."/>
<person name="Whitehead C."/>
<person name="Zhang E."/>
<person name="Kuffa P."/>
<person name="Yan C."/>
<person name="McConnell P."/>
<person name="Spessard C."/>
<person name="Banotai C."/>
<person name="Mueller W.T."/>
<person name="Delaney A."/>
<person name="Omer C."/>
<person name="Sebolt-Leopold J."/>
<person name="Dudley D.T."/>
<person name="Leung I.K."/>
<person name="Flamme C."/>
<person name="Warmus J."/>
<person name="Kaufman M."/>
<person name="Barrett S."/>
<person name="Tecle H."/>
<person name="Hasemann C.A."/>
</authorList>
<dbReference type="PubMed" id="15543157"/>
<dbReference type="DOI" id="10.1038/nsmb859"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 62-392 IN COMPLEX WITH ATP AND INHIBITOR</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2007" name="J. Med. Chem." volume="50" first="5090" last="5102">
<title>4-anilino-5-carboxamido-2-pyridone derivatives as noncompetitive inhibitors of mitogen-activated protein kinase kinase.</title>
<authorList>
<person name="Spicer J.A."/>
<person name="Rewcastle G.W."/>
<person name="Kaufman M.D."/>
<person name="Black S.L."/>
<person name="Plummer M.S."/>
<person name="Denny W.A."/>
<person name="Quin J. III"/>
<person name="Shahripour A.B."/>
<person name="Barrett S.D."/>
<person name="Whitehead C.E."/>
<person name="Milbank J.B."/>
<person name="Ohren J.F."/>
<person name="Gowan R.C."/>
<person name="Omer C."/>
<person name="Camp H.S."/>
<person name="Esmaeil N."/>
<person name="Moore K."/>
<person name="Sebolt-Leopold J.S."/>
<person name="Pryzbranowski S."/>
<person name="Merriman R.L."/>
<person name="Ortwine D.F."/>
<person name="Warmus J.S."/>
<person name="Flamme C.M."/>
<person name="Pavlovsky A.G."/>
<person name="Tecle H."/>
</authorList>
<dbReference type="PubMed" id="17880056"/>
<dbReference type="DOI" id="10.1021/jm0704548"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 62-393 IN COMPLEX WITH ATP AND INHIBITOR</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="Bioorg. Med. Chem. Lett." volume="18" first="6171" last="6174">
<title>2-Alkylamino- and alkoxy-substituted 2-amino-1,3,4-oxadiazoles-O-Alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase).</title>
<authorList>
<person name="Warmus J.S."/>
<person name="Flamme C."/>
<person name="Zhang L.Y."/>
<person name="Barrett S."/>
<person name="Bridges A."/>
<person name="Chen H."/>
<person name="Gowan R."/>
<person name="Kaufman M."/>
<person name="Sebolt-Leopold J."/>
<person name="Leopold W."/>
<person name="Merriman R."/>
<person name="Ohren J."/>
<person name="Pavlovsky A."/>
<person name="Przybranowski S."/>
<person name="Tecle H."/>
<person name="Valik H."/>
<person name="Whitehead C."/>
<person name="Zhang E."/>
</authorList>
<dbReference type="PubMed" id="18951019"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2008.10.015"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.62 ANGSTROMS) OF 62-393 IN COMPLEX WITH ATP AND INHIBITOR</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Biochemistry" volume="48" first="2661" last="2674">
<title>Crystal structures of MEK1 binary and ternary complexes with nucleotides and inhibitors.</title>
<authorList>
<person name="Fischmann T.O."/>
<person name="Smith C.K."/>
<person name="Mayhood T.W."/>
<person name="Myers J.E."/>
<person name="Reichert P."/>
<person name="Mannarino A."/>
<person name="Carr D."/>
<person name="Zhu H."/>
<person name="Wong J."/>
<person name="Yang R.S."/>
<person name="Le H.V."/>
<person name="Madison V.S."/>
</authorList>
<dbReference type="PubMed" id="19161339"/>
<dbReference type="DOI" id="10.1021/bi801898e"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 35-393 IN COMPLEX WITH ADP AND INHIBITOR</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Bioorg. Med. Chem. Lett." volume="19" first="226" last="229">
<title>Beyond the MEK-pocket: can current MEK kinase inhibitors be utilized to synthesize novel type III NCKIs? Does the MEK-pocket exist in kinases other than MEK?</title>
<authorList>
<person name="Tecle H."/>
<person name="Shao J."/>
<person name="Li Y."/>
<person name="Kothe M."/>
<person name="Kazmirski S."/>
<person name="Penzotti J."/>
<person name="Ding Y.H."/>
<person name="Ohren J."/>
<person name="Moshinsky D."/>
<person name="Coli R."/>
<person name="Jhawar N."/>
<person name="Bora E."/>
<person name="Jacques-O'Hagan S."/>
<person name="Wu J."/>
</authorList>
<dbReference type="PubMed" id="19019675"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2008.10.108"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 62-382 IN COMPLEX WITH ATP AND INHIBITOR</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="Cancer Res." volume="69" first="6839" last="6847">
<title>RDEA119/BAY 869766: a potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancer.</title>
<authorList>
<person name="Iverson C."/>
<person name="Larson G."/>
<person name="Lai C."/>
<person name="Yeh L.T."/>
<person name="Dadson C."/>
<person name="Weingarten P."/>
<person name="Appleby T."/>
<person name="Vo T."/>
<person name="Maderna A."/>
<person name="Vernier J.M."/>
<person name="Hamatake R."/>
<person name="Miner J.N."/>
<person name="Quart B."/>
</authorList>
<dbReference type="PubMed" id="19706763"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-09-0679"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 62-393 IN COMPLEX WITH ATP AND INHIBITOR</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="Bioorg. Med. Chem. Lett." volume="20" first="4156" last="4158">
<title>Structure-based design and synthesis of pyrrole derivatives as MEK inhibitors.</title>
<authorList>
<person name="Wallace M.B."/>
<person name="Adams M.E."/>
<person name="Kanouni T."/>
<person name="Mol C.D."/>
<person name="Dougan D.R."/>
<person name="Feher V.A."/>
<person name="O'Connell S.M."/>
<person name="Shi L."/>
<person name="Halkowycz P."/>
<person name="Dong Q."/>
</authorList>
<dbReference type="PubMed" id="20621728"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2010.05.058"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 62-382 IN COMPLEX WITH ADP AND INHIBITOR</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="Bioorg. Med. Chem. Lett." volume="21" first="1315" last="1319">
<title>Discovery of TAK-733, a potent and selective MEK allosteric site inhibitor for the treatment of cancer.</title>
<authorList>
<person name="Dong Q."/>
<person name="Dougan D.R."/>
<person name="Gong X."/>
<person name="Halkowycz P."/>
<person name="Jin B."/>
<person name="Kanouni T."/>
<person name="O'Connell S.M."/>
<person name="Scorah N."/>
<person name="Shi L."/>
<person name="Wallace M.B."/>
<person name="Zhou F."/>
</authorList>
<dbReference type="PubMed" id="21310613"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2011.01.071"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 62-382 IN COMPLEX WITH ATP AND INHIBITOR</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="Bioorg. Med. Chem. Lett." volume="21" first="1795" last="1801">
<title>Design and synthesis of novel allosteric MEK inhibitor CH4987655 as an orally available anticancer agent.</title>
<authorList>
<person name="Isshiki Y."/>
<person name="Kohchi Y."/>
<person name="Iikura H."/>
<person name="Matsubara Y."/>
<person name="Asoh K."/>
<person name="Murata T."/>
<person name="Kohchi M."/>
<person name="Mizuguchi E."/>
<person name="Tsujii S."/>
<person name="Hattori K."/>
<person name="Miura T."/>
<person name="Yoshimura Y."/>
<person name="Aida S."/>
<person name="Miwa M."/>
<person name="Saitoh R."/>
<person name="Murao N."/>
<person name="Okabe H."/>
<person name="Belunis C."/>
<person name="Janson C."/>
<person name="Lukacs C."/>
<person name="Schuck V."/>
<person name="Shimma N."/>
</authorList>
<dbReference type="PubMed" id="21316218"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2011.01.062"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 62-393</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="Science" volume="311" first="1287" last="1290">
<title>Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.</title>
<authorList>
<person name="Rodriguez-Viciana P."/>
<person name="Tetsu O."/>
<person name="Tidyman W.E."/>
<person name="Estep A.L."/>
<person name="Conger B.A."/>
<person name="Cruz M.S."/>
<person name="McCormick F."/>
<person name="Rauen K.A."/>
</authorList>
<dbReference type="PubMed" id="16439621"/>
<dbReference type="DOI" id="10.1126/science.1124642"/>
</citation>
<scope>VARIANTS CFC3 SER-53 AND CYS-130</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2008" name="Clin. Genet." volume="73" first="62" last="70">
<title>Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome.</title>
<authorList>
<person name="Schulz A.L."/>
<person name="Albrecht B."/>
<person name="Arici C."/>
<person name="van der Burgt I."/>
<person name="Buske A."/>
<person name="Gillessen-Kaesbach G."/>
<person name="Heller R."/>
<person name="Horn D."/>
<person name="Hubner C.A."/>
<person name="Korenke G.C."/>
<person name="Konig R."/>
<person name="Kress W."/>
<person name="Kruger G."/>
<person name="Meinecke P."/>
<person name="Mucke J."/>
<person name="Plecko B."/>
<person name="Rossier E."/>
<person name="Schinzel A."/>
<person name="Schulze A."/>
<person name="Seemanova E."/>
<person name="Seidel H."/>
<person name="Spranger S."/>
<person name="Tuysuz B."/>
<person name="Uhrig S."/>
<person name="Wieczorek D."/>
<person name="Kutsche K."/>
<person name="Zenker M."/>
</authorList>
<dbReference type="PubMed" id="18042262"/>
<dbReference type="DOI" id="10.1111/j.1399-0004.2007.00931.x"/>
</citation>
<scope>VARIANT CFC3 VAL-128</scope>
</reference>
<comment type="function">
<text evidence="14 19">Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="6">Ras proteins such as HRAS mediate the activation of RAF proteins such as RAF1 or BRAF which in turn activate extracellular signal-regulated kinases (ERK) through MAPK (mitogen-activated protein kinases) and ERK kinases MAP2K1/MEK1 and MAP2K2/MEK2. Activation occurs through phosphorylation of Ser-218 and Ser-222. MAP2K1/MEK1 is also the target of negative feed-back regulation by its substrate kinases, such as MAPK1/ERK2. These phosphorylate MAP2K1/MEK1 on Thr-292, thereby facilitating dephosphorylation of the activating residues Ser-218 and Ser-222. Inhibited by serine/threonine phosphatase 2A (By similarity). Many inhibitors have been identified including pyrrole derivatives, TAK-733 (one of a series of 8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione derivatives), CH4987655 and RDEA119/BAY 869766.</text>
</comment>
<comment type="subunit">
<text evidence="7 8 9 12 18 19 22 26 29">Found in a complex with at least BRAF, HRAS, MAP2K1, MAPK3/ERK1 and RGS14. Forms a heterodimer with MAP2K2/MEK2. Forms heterodimers with KSR2 which further dimerize to form tetramers. Interacts with ARBB2, LAMTOR3, MAPK1/ERK2, MORG1 and RAF1 (By similarity). Interacts with PPARG and with isoform 1 of VRK2 (PubMed:20679487, PubMed:17101779). Interacts with Yersinia yopJ (PubMed:16728640). Interacts with SGK1 (PubMed:19447520). Interacts with BIRC6/bruce (PubMed:18329369). Interacts with KSR1 (PubMed:10409742).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-492564"/>
<interactant intactId="EBI-744695">
<id>Q8N9N5</id>
<label>BANP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-492564"/>
<interactant intactId="EBI-1765160">
<id>Q9NR09</id>
<label>BIRC6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-492564"/>
<interactant intactId="EBI-365980">
<id>P15056</id>
<label>BRAF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>54</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-492564"/>
<interactant intactId="EBI-307461">
<id>Q9Y297</id>
<label>BTRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-492564"/>
<interactant intactId="EBI-4567563">
<id>O15519-1</id>
<label>CFLAR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-492564"/>
<interactant intactId="EBI-959949">
<id>P28482</id>
<label>MAPK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-492564"/>
<interactant intactId="EBI-73995">
<id>P27361</id>
<label>MAPK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-492564"/>
<interactant intactId="EBI-365996">
<id>P04049</id>
<label>RAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>31</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-492564"/>
<interactant intactId="EBI-1207615">
<id>Q86Y07</id>
<label>VRK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-492564"/>
<interactant intactId="EBI-1207633">
<id>Q86Y07-1</id>
<label>VRK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-492564"/>
<interactant intactId="EBI-1044059">
<id>P46937</id>
<label>YAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="14">Cytoplasm</location>
<location evidence="14">Cytoskeleton</location>
<location evidence="14">Microtubule organizing center</location>
<location evidence="14">Centrosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="14">Cytoplasm</location>
<location evidence="14">Cytoskeleton</location>
<location evidence="14">Microtubule organizing center</location>
<location evidence="14">Spindle pole body</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="12 19">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="12">Membrane</location>
<topology evidence="12">Peripheral membrane protein</topology>
</subcellularLocation>
<text evidence="12 14">Localizes at centrosomes during prometaphase, midzone during anaphase and midbody during telophase/cytokinesis (PubMed:14737111). Membrane localization is probably regulated by its interaction with KSR1 (PubMed:10409742).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q02750-1</id>
<name>1</name>
<name>MKK1a</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q02750-2</id>
<name>2</name>
<name>MKK1b</name>
<sequence type="described" ref="VSP_040500"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="13">Widely expressed, with extremely low levels in brain.</text>
</comment>
<comment type="domain">
<text evidence="6">The proline-rich region localized between residues 270 and 307 is important for binding to RAF1 and activation of MAP2K1/MEK1.</text>
</comment>
<comment type="PTM">
<text evidence="16 31">Phosphorylation at Ser-218 and Ser-222 by MAP kinase kinase kinases (RAF or MEKK1) positively regulates kinase activity. Also phosphorylated at Thr-292 by MAPK1/ERK2 and at Ser-298 by PAK. MAPK1/ERK2 phosphorylation of Thr-292 occurs in response to cellular adhesion and leads to inhibition of Ser-298 phosphorylation by PAK.</text>
</comment>
<comment type="PTM">
<text evidence="18">Acetylation by Yersinia yopJ prevents phosphorylation and activation, thus blocking the MAPK signaling pathway.</text>
</comment>
<comment type="disease" evidence="17 21">
<disease id="DI-03780">
<name>Cardiofaciocutaneous syndrome 3</name>
<acronym>CFC3</acronym>
<description>A form of cardiofaciocutaneous syndrome, a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. Distinctive features of CFC3 include macrostomia and horizontal shape of palpebral fissures.</description>
<dbReference type="MIM" id="615279"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="33">Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. MAP kinase kinase subfamily.</text>
</comment>
<dbReference type="EC" id="2.7.12.2"/>
<dbReference type="EMBL" id="L05624">
<property type="protein sequence ID" value="AAA36318.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L11284">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10216.1">
<molecule id="Q02750-1"/>
</dbReference>
<dbReference type="PIR" id="A45100">
<property type="entry name" value="A45100"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002746.1">
<molecule id="Q02750-1"/>
<property type="nucleotide sequence ID" value="NM_002755.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016877900.1">
<molecule id="Q02750-2"/>
<property type="nucleotide sequence ID" value="XM_017022411.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.145442"/>
<dbReference type="UniGene" id="Hs.677223"/>
<dbReference type="PDB" id="1S9J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=62-393"/>
</dbReference>
<dbReference type="PDB" id="2P55">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=62-393"/>
</dbReference>
<dbReference type="PDB" id="3DV3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=62-382"/>
</dbReference>
<dbReference type="PDB" id="3DY7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=62-393"/>
</dbReference>
<dbReference type="PDB" id="3E8N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=62-393"/>
</dbReference>
<dbReference type="PDB" id="3EQB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.62"/>
<property type="chains" value="A=62-393"/>
</dbReference>
<dbReference type="PDB" id="3EQC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=35-393"/>
</dbReference>
<dbReference type="PDB" id="3EQD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=35-393"/>
</dbReference>
<dbReference type="PDB" id="3EQF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=35-393"/>
</dbReference>
<dbReference type="PDB" id="3EQG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=35-393"/>
</dbReference>
<dbReference type="PDB" id="3EQH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=35-393"/>
</dbReference>
<dbReference type="PDB" id="3EQI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=35-393"/>
</dbReference>
<dbReference type="PDB" id="3MBL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=62-382"/>
</dbReference>
<dbReference type="PDB" id="3ORN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=62-393"/>
</dbReference>
<dbReference type="PDB" id="3OS3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=62-393"/>
</dbReference>
<dbReference type="PDB" id="3PP1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=62-382"/>
</dbReference>
<dbReference type="PDB" id="3SLS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=45-263, A/B=308-383"/>
</dbReference>
<dbReference type="PDB" id="3V01">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=62-393"/>
</dbReference>
<dbReference type="PDB" id="3V04">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=62-393"/>
</dbReference>
<dbReference type="PDB" id="3VVH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B/C=62-393"/>
</dbReference>
<dbReference type="PDB" id="3W8Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=39-382"/>
</dbReference>
<dbReference type="PDB" id="3WIG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=62-393"/>
</dbReference>
<dbReference type="PDB" id="3ZLS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=37-383"/>
</dbReference>
<dbReference type="PDB" id="3ZLW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.12"/>
<property type="chains" value="A=37-383"/>
</dbReference>
<dbReference type="PDB" id="3ZLX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=37-383"/>
</dbReference>
<dbReference type="PDB" id="3ZLY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.11"/>
<property type="chains" value="A=37-383"/>
</dbReference>
<dbReference type="PDB" id="3ZM4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.37"/>
<property type="chains" value="A=37-383"/>
</dbReference>
<dbReference type="PDB" id="4AN2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=61-392"/>
</dbReference>
<dbReference type="PDB" id="4AN3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=61-392"/>
</dbReference>
<dbReference type="PDB" id="4AN9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=61-392"/>
</dbReference>
<dbReference type="PDB" id="4ANB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=61-392"/>
</dbReference>
<dbReference type="PDB" id="4ARK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=62-393"/>
</dbReference>
<dbReference type="PDB" id="4LMN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=62-393"/>
</dbReference>
<dbReference type="PDB" id="4MNE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A/D/E/H=62-393"/>
</dbReference>
<dbReference type="PDB" id="4U7Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=62-393"/>
</dbReference>
<dbReference type="PDB" id="4U80">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=62-393"/>
</dbReference>
<dbReference type="PDB" id="4U81">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=62-393"/>
</dbReference>
<dbReference type="PDB" id="5BX0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.93"/>
<property type="chains" value="A=37-383"/>
</dbReference>
<dbReference type="PDB" id="5EYM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=35-393"/>
</dbReference>
<dbReference type="PDBsum" id="1S9J"/>
<dbReference type="PDBsum" id="2P55"/>
<dbReference type="PDBsum" id="3DV3"/>
<dbReference type="PDBsum" id="3DY7"/>
<dbReference type="PDBsum" id="3E8N"/>
<dbReference type="PDBsum" id="3EQB"/>
<dbReference type="PDBsum" id="3EQC"/>
<dbReference type="PDBsum" id="3EQD"/>
<dbReference type="PDBsum" id="3EQF"/>
<dbReference type="PDBsum" id="3EQG"/>
<dbReference type="PDBsum" id="3EQH"/>
<dbReference type="PDBsum" id="3EQI"/>
<dbReference type="PDBsum" id="3MBL"/>
<dbReference type="PDBsum" id="3ORN"/>
<dbReference type="PDBsum" id="3OS3"/>
<dbReference type="PDBsum" id="3PP1"/>
<dbReference type="PDBsum" id="3SLS"/>
<dbReference type="PDBsum" id="3V01"/>
<dbReference type="PDBsum" id="3V04"/>
<dbReference type="PDBsum" id="3VVH"/>
<dbReference type="PDBsum" id="3W8Q"/>
<dbReference type="PDBsum" id="3WIG"/>
<dbReference type="PDBsum" id="3ZLS"/>
<dbReference type="PDBsum" id="3ZLW"/>
<dbReference type="PDBsum" id="3ZLX"/>
<dbReference type="PDBsum" id="3ZLY"/>
<dbReference type="PDBsum" id="3ZM4"/>
<dbReference type="PDBsum" id="4AN2"/>
<dbReference type="PDBsum" id="4AN3"/>
<dbReference type="PDBsum" id="4AN9"/>
<dbReference type="PDBsum" id="4ANB"/>
<dbReference type="PDBsum" id="4ARK"/>
<dbReference type="PDBsum" id="4LMN"/>
<dbReference type="PDBsum" id="4MNE"/>
<dbReference type="PDBsum" id="4U7Z"/>
<dbReference type="PDBsum" id="4U80"/>
<dbReference type="PDBsum" id="4U81"/>
<dbReference type="PDBsum" id="5BX0"/>
<dbReference type="PDBsum" id="5EYM"/>
<dbReference type="ProteinModelPortal" id="Q02750"/>
<dbReference type="SMR" id="Q02750"/>
<dbReference type="BioGrid" id="111590">
<property type="interactions" value="65"/>
</dbReference>
<dbReference type="DIP" id="DIP-201N"/>
<dbReference type="IntAct" id="Q02750">
<property type="interactions" value="63"/>
</dbReference>
<dbReference type="MINT" id="MINT-99632"/>
<dbReference type="STRING" id="9606.ENSP00000302486"/>
<dbReference type="BindingDB" id="Q02750"/>
<dbReference type="ChEMBL" id="CHEMBL3587"/>
<dbReference type="DrugBank" id="DB06616">
<property type="generic name" value="Bosutinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05239">
<property type="generic name" value="Cobimetinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB02152">
<property type="generic name" value="K-252a"/>
</dbReference>
<dbReference type="DrugBank" id="DB08911">
<property type="generic name" value="Trametinib"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2062"/>
<dbReference type="iPTMnet" id="Q02750"/>
<dbReference type="PhosphoSitePlus" id="Q02750"/>
<dbReference type="BioMuta" id="MAP2K1"/>
<dbReference type="DMDM" id="400274"/>
<dbReference type="EPD" id="Q02750"/>
<dbReference type="MaxQB" id="Q02750"/>
<dbReference type="PaxDb" id="Q02750"/>
<dbReference type="PeptideAtlas" id="Q02750"/>
<dbReference type="PRIDE" id="Q02750"/>
<dbReference type="DNASU" id="5604"/>
<dbReference type="Ensembl" id="ENST00000307102">
<molecule id="Q02750-1"/>
<property type="protein sequence ID" value="ENSP00000302486"/>
<property type="gene ID" value="ENSG00000169032"/>
</dbReference>
<dbReference type="GeneID" id="5604"/>
<dbReference type="KEGG" id="hsa:5604"/>
<dbReference type="UCSC" id="uc010bhq.4">
<molecule id="Q02750-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5604"/>
<dbReference type="DisGeNET" id="5604"/>
<dbReference type="GeneCards" id="MAP2K1"/>
<dbReference type="GeneReviews" id="MAP2K1"/>
<dbReference type="HGNC" id="HGNC:6840">
<property type="gene designation" value="MAP2K1"/>
</dbReference>
<dbReference type="HPA" id="CAB003834"/>
<dbReference type="HPA" id="HPA026430"/>
<dbReference type="MalaCards" id="MAP2K1"/>
<dbReference type="MIM" id="176872">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="615279">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q02750"/>
<dbReference type="OpenTargets" id="ENSG00000169032"/>
<dbReference type="Orphanet" id="1340">
<property type="disease" value="Cardiofaciocutaneous syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA30584"/>
<dbReference type="eggNOG" id="KOG0581">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XQ5A">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119199"/>
<dbReference type="HOGENOM" id="HOG000234206"/>
<dbReference type="HOVERGEN" id="HBG108518"/>
<dbReference type="InParanoid" id="Q02750"/>
<dbReference type="KO" id="K04368"/>
<dbReference type="OMA" id="LMNHEWI"/>
<dbReference type="OrthoDB" id="EOG091G0DEC"/>
<dbReference type="PhylomeDB" id="Q02750"/>
<dbReference type="TreeFam" id="TF105137"/>
<dbReference type="BRENDA" id="2.7.12.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-110056">
<property type="pathway name" value="MAPK3 (ERK1) activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-445144">
<property type="pathway name" value="Signal transduction by L1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5210891">
<property type="pathway name" value="Uptake and function of anthrax toxins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673000">
<property type="pathway name" value="RAF activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674135">
<property type="pathway name" value="MAP2K and MAPK activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674499">
<property type="pathway name" value="Negative feedback regulation of MAPK pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5684264">
<property type="pathway name" value="MAP3K8 (TPL2)-dependent MAPK1/3 activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802946">
<property type="pathway name" value="Signaling by moderate kinase activity BRAF mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802948">
<property type="pathway name" value="Signaling by high-kinase activity BRAF mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802949">
<property type="pathway name" value="Signaling by RAS mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802952">
<property type="pathway name" value="Signaling by BRAF and RAF fusions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802955">
<property type="pathway name" value="Paradoxical activation of RAF signaling by kinase inactive BRAF"/>
</dbReference>
<dbReference type="SignaLink" id="Q02750"/>
<dbReference type="SIGNOR" id="Q02750"/>
<dbReference type="ChiTaRS" id="MAP2K1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q02750"/>
<dbReference type="GeneWiki" id="MAP2K1"/>
<dbReference type="GenomeRNAi" id="5604"/>
<dbReference type="PMAP-CutDB" id="Q02750"/>
<dbReference type="PRO" id="PR:Q02750"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 15"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000169032"/>
<dbReference type="CleanEx" id="HS_MAP2K1"/>
<dbReference type="ExpressionAtlas" id="Q02750">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q02750">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005769">
<property type="term" value="C:early endosome"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005770">
<property type="term" value="C:late endosome"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005815">
<property type="term" value="C:microtubule organizing center"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004708">
<property type="term" value="F:MAP kinase kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0047485">
<property type="term" value="F:protein N-terminus binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043539">
<property type="term" value="F:protein serine/threonine kinase activator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004712">
<property type="term" value="F:protein serine/threonine/tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004728">
<property type="term" value="F:signal transducer, downstream of receptor, with protein tyrosine phosphatase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004702">
<property type="term" value="F:signal transducer, downstream of receptor, with serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000187">
<property type="term" value="P:activation of MAPK activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0060020">
<property type="term" value="P:Bergmann glial cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007050">
<property type="term" value="P:cell cycle arrest"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048870">
<property type="term" value="P:cell motility"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090398">
<property type="term" value="P:cellular senescence"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0021697">
<property type="term" value="P:cerebellar cortex formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006935">
<property type="term" value="P:chemotaxis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0060502">
<property type="term" value="P:epithelial cell proliferation involved in lung morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070371">
<property type="term" value="P:ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060324">
<property type="term" value="P:face development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030216">
<property type="term" value="P:keratinocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060711">
<property type="term" value="P:labyrinthine layer development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006928">
<property type="term" value="P:movement of cell or subcellular component"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030182">
<property type="term" value="P:neuron differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060674">
<property type="term" value="P:placenta blood vessel development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050772">
<property type="term" value="P:positive regulation of axonogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903800">
<property type="term" value="P:positive regulation of production of miRNAs involved in gene silencing by miRNA"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071902">
<property type="term" value="P:positive regulation of protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035897">
<property type="term" value="P:proteolysis in other organism"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048679">
<property type="term" value="P:regulation of axon regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000641">
<property type="term" value="P:regulation of early endosome to late endosome transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090170">
<property type="term" value="P:regulation of Golgi inheritance"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032872">
<property type="term" value="P:regulation of stress-activated MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0048538">
<property type="term" value="P:thymus development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030878">
<property type="term" value="P:thyroid gland development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060440">
<property type="term" value="P:trachea formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0122">Cardiomyopathy</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0038">Ectodermal dysplasia</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<feature type="initiator methionine" description="Removed" evidence="7">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Dual specificity mitogen-activated protein kinase kinase 1" id="PRO_0000086365">
<location>
<begin position="2"/>
<end position="393"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="10">
<location>
<begin position="68"/>
<end position="361"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="10 15 20 23 24 27 30">
<location>
<begin position="74"/>
<end position="82"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="10 15 20 23 24 27 30">
<location>
<begin position="143"/>
<end position="146"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="10 15 20 23 24 27 30">
<location>
<begin position="150"/>
<end position="153"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="10 15 20 23 24 27 30">
<location>
<begin position="192"/>
<end position="195"/>
</location>
</feature>
<feature type="region of interest" description="Inhibitor binding">
<location>
<begin position="77"/>
<end position="78"/>
</location>
</feature>
<feature type="region of interest" description="Inhibitor binding">
<location>
<begin position="144"/>
<end position="146"/>
</location>
</feature>
<feature type="region of interest" description="Inhibitor binding">
<location>
<begin position="208"/>
<end position="212"/>
</location>
</feature>
<feature type="region of interest" description="RAF1-binding" evidence="6">
<location>
<begin position="270"/>
<end position="307"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="262"/>
<end position="307"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="10 11">
<location>
<position position="190"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor; via carbonyl oxygen" evidence="15 20 23 24 25 27 28 30">
<location>
<position position="77"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor; via amide nitrogen and carbonyl oxygen" evidence="15 20 23 24 25 27 28 30">
<location>
<position position="78"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="10 15 20 23 24 27 30">
<location>
<position position="97"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor" evidence="15 20 23 24 25 27 28 30">
<location>
<position position="97"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor" evidence="15 20 23 24 25 27 28 30">
<location>
<position position="190"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor; via carbonyl oxygen" evidence="15 20 23 24 25 27 28 30">
<location>
<position position="194"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="10 15 20 23 24 27 30">
<location>
<position position="208"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor" evidence="15 20 23 24 25 27 28 30">
<location>
<position position="208"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor; via amide nitrogen" evidence="15 20 23 24 25 27 28 30">
<location>
<position position="212"/>
</location>
</feature>
<feature type="site" description="Cleavage; by anthrax lethal factor">
<location>
<begin position="8"/>
<end position="9"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by RAF" evidence="12 31">
<location>
<position position="218"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by RAF" evidence="31">
<location>
<position position="222"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5">
<location>
<position position="286"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAPK1" evidence="6">
<location>
<position position="292"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PAK" evidence="16">
<location>
<position position="298"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_040500" evidence="32">
<location>
<begin position="147"/>
<end position="172"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC3; dbSNP:rs121908594." id="VAR_035093" evidence="17">
<original>F</original>
<variation>S</variation>
<location>
<position position="53"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC3; dbSNP:rs730880508." id="VAR_069780" evidence="21">
<original>G</original>
<variation>V</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC3; dbSNP:rs121908595." id="VAR_035094" evidence="17">
<original>Y</original>
<variation>C</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inactivation." evidence="31">
<original>K</original>
<variation>R</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="mutagenesis site" description="No loss of activity." evidence="31">
<original>S</original>
<variation>A</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="mutagenesis site" description="No loss of activity." evidence="31">
<original>S</original>
<variation>A</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inactivation." evidence="31">
<original>S</original>
<variation>A</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inactivation." evidence="31">
<original>S</original>
<variation>A</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AA sequence." ref="3" evidence="33">
<original>A</original>
<variation>R</variation>
<location>
<position position="52"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AA sequence." ref="3" evidence="33">
<location>
<position position="180"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="44"/>
<end position="58"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="65"/>
<end position="67"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="68"/>
<end position="76"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="81"/>
<end position="87"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="88"/>
<end position="90"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="93"/>
<end position="100"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="105"/>
<end position="115"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="116"/>
<end position="120"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="129"/>
<end position="135"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="138"/>
<end position="143"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="151"/>
<end position="158"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="163"/>
<end position="184"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="193"/>
<end position="195"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="196"/>
<end position="198"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="200"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="204"/>
<end position="206"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="213"/>
<end position="218"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="221"/>
<end position="223"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="227"/>
<end position="229"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="232"/>
<end position="235"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="242"/>
<end position="258"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="268"/>
<end position="275"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="310"/>
<end position="319"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="327"/>
<end position="329"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="332"/>
<end position="342"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="346"/>
<end position="348"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="352"/>
<end position="356"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="359"/>
<end position="366"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="371"/>
<end position="379"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3DY7"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3EQC"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3VVH"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4AN3"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250"/>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P29678"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P31938"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q01986"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10409742"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1281467"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14737111"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15543157"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16129686"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16439621"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16728640"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17101779"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17880056"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18042262"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18329369"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18951019"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19019675"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19161339"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19447520"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19706763"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20621728"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20679487"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21310613"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8131746"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1281467"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000305"/>
<sequence length="393" mass="43439" checksum="0344118FFC842D51" modified="2007-01-23" version="2">
MPKKKPTPIQLNPAPDGSAVNGTSSAETNLEALQKKLEELELDEQQRKRLEAFLTQKQKV
GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE
CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL
REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY
SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY
GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF
IKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGV
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>